Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size Yamakuchi M; Greer JJ; Cameron SJ; Matsushita K; Morrell CN; Talbot-Fox K; Baldwin WM 3rd; Lefer DJ; Lowenstein CJCirc Res 2005[Jun]; 96 (11): 1185-92Three-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors protect the vasculature from inflammation and atherosclerosis by cholesterol dependent and cholesterol independent mechanisms. We hypothesized that HMG-CoA reductase inhibitors decrease exocytosis of Weibel-Palade bodies, endothelial cell granules whose contents promote thrombosis and vascular inflammation. We pretreated human aortic endothelial cells with simvastatin for 24 hours, then stimulated the cells with thrombin, and measured the amount of vWF released into the media. We then measured the effect of simvastatin on myocardial infarction in mice. Simvastatin decreased thrombin-stimulated Weibel-Palade body exocytosis by 89%. Simvastatin inhibited exocytosis in part by increasing synthesis of nitric oxide (NO), which S-nitrosylated N-ethylmaleimide sensitive factor (NSF), a critical regulator of exocytosis. Simvastatin treatment attenuated myocardial infarct size by 58% in wild-type but not eNOS knockout mice. Furthermore, simvastatin decreased endothelial exocytosis and neutrophil infiltration into ischemic-reperfused myocardium, which was mediated in part by P-selectin contained in Weibel-Palade bodies. However, simvastatin did not affect exocytosis and inflammation in myocardial infarcts of eNOS knockout mice. Inhibition of endothelial exocytosis is a novel mechanism by which HMG-CoA reductase inhibitors may reduce vascular inflammation, inhibit thrombosis, and protect the ischemic myocardium. These findings may explain part of the pleiotropic effects of statin therapy for patients with cardiovascular disease.|Animals[MESH]|Cells, Cultured[MESH]|Clinical Trials as Topic[MESH]|Endothelium, Vascular/*drug effects/metabolism[MESH]|Exocytosis/*drug effects[MESH]|Humans[MESH]|Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology/therapeutic use[MESH]|Mice[MESH]|Mice, Inbred C57BL[MESH]|Myocardial Infarction/*drug therapy/metabolism[MESH]|N-Ethylmaleimide-Sensitive Proteins[MESH]|Neutrophil Infiltration/drug effects[MESH]|Nitric Oxide Synthase Type II[MESH]|Nitric Oxide Synthase Type III[MESH]|Nitric Oxide Synthase/physiology[MESH]|Nitric Oxide/physiology[MESH]|Simvastatin/pharmacology[MESH]|Vesicular Transport Proteins/metabolism[MESH]|Weibel-Palade Bodies/drug effects[MESH] |
